Anastrozole
Product Images NDC 21695-990

6 FDA label images from Rebel Distributors Corp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Anastrozole (NDC 21695-990). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Of Chemical Structure (611e1f43 1442 4cbb B7eb B65de15c6c70 01)

Image Of Chemical Structure (611e1f43 1442 4cbb B7eb B65de15c6c70 01)
Chemical structure of Anastrozole, showing its molecular framework with a triazole ring and substituted benzene ring including cyano and methyl groups.*
FDA Label Image

Image Of Figure 1 (611e1f43 1442 4cbb B7eb B65de15c6c70 02)

Image Of Figure 1 (611e1f43 1442 4cbb B7eb B65de15c6c70 02)
Kaplan Meier survival curve chart showing disease-free survival over time in months for patients treated with Anastrozole or Tamoxifen in the ATAC trial. The graph plots proportion alive and disease-free on the vertical axis, featuring curves for both treatments and patient risk numbers at various time points.*
FDA Label Image

Image Of Figure 2 (611e1f43 1442 4cbb B7eb B65de15c6c70 03)

Image Of Figure 2 (611e1f43 1442 4cbb B7eb B65de15c6c70 03)
A line graph depicting disease-free survival over time in months for patients with hormone receptor-positive subpopulation receiving either anastrozole or tamoxifen monotherapy in the ATAC trial. The vertical axis shows the proportion alive and disease-free, while the horizontal axis shows disease-free survival in months up to 90 months. Patient numbers at risk are listed by treatment group below the graph.*
FDA Label Image

Image Of Figure 3 (611e1f43 1442 4cbb B7eb B65de15c6c70 04)

Image Of Figure 3 (611e1f43 1442 4cbb B7eb B65de15c6c70 04)
A Kaplan-Meier survival curve chart showing the probability of time to disease progression in months for patients in Trial 0030. Two treatment arms are compared: Anastrozole and Tamoxifen. The y-axis displays the proportion of patients not progressing, and the x-axis displays time to progression in months. Patient counts at risk are shown below the x-axis at various time points.*
FDA Label Image

Image Of Figure 4 (611e1f43 1442 4cbb B7eb B65de15c6c70 05)

Image Of Figure 4 (611e1f43 1442 4cbb B7eb B65de15c6c70 05)
A Kaplan-Meier survival curve graph showing the probability of time to progression for randomized patients treated with Anastrozole versus Tamoxifen. The x-axis represents time to progression in months, and the y-axis shows the proportion not progressing. Patient risk counts are shown below the x-axis for each time point.*
FDA Label Image

Anastrozole 1mg (611e1f43 1442 4cbb B7eb B65de15c6c70 06)

Anastrozole 1mg (611e1f43 1442 4cbb B7eb B65de15c6c70 06)
Anastrozole 1 mg Tablets package label from Rebel Distributors Corp with NDC 21695-990-30. The label states each tablet contains 1 mg of anastrozole USP, white round tablets with imprint code "AN; 1". It includes product ID RA099030 and marks the product as RX only. Distributed by Physician Partner, Thousand Oaks, CA. Storage instructions for controlled room temperature are provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.